| Table VI.3: The Number of States Reporting Each Level of Satisfaction with Communication and Interactions with Other State Pharmacy Regulatory Bodies Related to Drug Compounding | ||||||
|---|---|---|---|---|---|---|
| Number of statesa | ||||||
| Very satisfied | Somewhat satisfied | Neither satisfied nor dissatisfied | Somewhat dissatisfied | Very dissatisfied | Don't know | No response |
| 30 | 5 | 3 | 1 | 0 | 1 | 2 |
| Source: GAO survey of state pharmacy regulatory bodies, survey question 43. | GAO-17-363SP |
| Notes: GAO surveyed the state pharmacy regulatory bodies in the 50 states, the District of Columbia, Guam, Puerto Rico, and the U.S. Virgin Islands, and all but 4 completed the survey. |
| aForty-two states that reported having had communication or interactions with representatives of state pharmacy regulatory bodies in other states related to drug compounding issues were asked about their overall satisfaction with that communication or interaction. |